The use of antiarrhythmic agents in heart failure: implications of CAST.
Gottlieb
S S
SS
Department of Medicine, University of Maryland School of Medicine, Baltimore 21201.
D000813:Anilides / Q000009:adverse effects; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000209:etiology; D002986:Clinical Trials as Topic; D016700:Encainide; D005424:Flecainide / Q000009:adverse effects; D006333:Heart Failure / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D006439:Hemodynamics; D006801:Humans; D012307:Risk Factors
D000813:Anilides; D000889:Anti-Arrhythmia Agents; D005424:Flecainide; D016700:Encainide